These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 24896249)

  • 1. Is there a paradox in obesity?
    Goyal A; Nimmakayala KR; Zonszein J
    Cardiol Rev; 2014; 22(4):163-70. PubMed ID: 24896249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Handgrip strength attenuates the adverse effects of overweight on cardiometabolic risk factors among collegiate students but not in individuals with higher fat levels.
    Garcia-Hermoso A; Tordecilla-Sanders A; Correa-Bautista JE; Peterson MD; Izquierdo M; Prieto-Benavides D; Sandoval-Cuellar C; González-Ruíz K; Ramírez-Vélez R
    Sci Rep; 2019 May; 9(1):6986. PubMed ID: 31061449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing adiposity and the presence of cardiometabolic morbidity is associated with increased Covid-19-related mortality: results from the UK Biobank.
    Patel KHK; Li X; Quint JK; Ware JS; Peters NS; Ng FS
    BMC Endocr Disord; 2021 Jul; 21(1):144. PubMed ID: 34217276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
    Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting adipose tissue inflammation to treat the underlying basis of the metabolic complications of obesity.
    Goran MI; Alderete TL
    Nestle Nutr Inst Workshop Ser; 2012; 73():49-60; discussion p61-6. PubMed ID: 23128765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramuscular fat and associations with metabolic risk factors in the Framingham Heart Study.
    Therkelsen KE; Pedley A; Speliotes EK; Massaro JM; Murabito J; Hoffmann U; Fox CS
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):863-70. PubMed ID: 23349188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic consequences of adipose tissue dysfunction and not adiposity per se increase the risk of cardiovascular events and mortality in patients with type 2 diabetes.
    Franssens BT; Westerink J; van der Graaf Y; Nathoe HM; Visseren FLJ;
    Int J Cardiol; 2016 Nov; 222():72-77. PubMed ID: 27458826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound-assessed visceral fat and associations with glucose homeostasis and cardiovascular risk in clinical practice.
    Bellan M; Menegatti M; Ferrari C; Carnevale Schianca GP; Pirisi M
    Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):610-617. PubMed ID: 29656956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of general and abdominal adiposity in the occurrence of new vascular events and mortality in patients with various manifestations of vascular disease.
    Kanhai DA; Kappelle LJ; van der Graaf Y; Uiterwaal CS; Visseren FL;
    Int J Obes (Lond); 2012 May; 36(5):695-702. PubMed ID: 21712810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolically Healthy and Unhealthy Normal Weight and Obesity.
    Stefan N
    Endocrinol Metab (Seoul); 2020 Sep; 35(3):487-493. PubMed ID: 32814419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk of adipokines: a review.
    Dutheil F; Gordon BA; Naughton G; Crendal E; Courteix D; Chaplais E; Thivel D; Lac G; Benson AC
    J Int Med Res; 2018 Jun; 46(6):2082-2095. PubMed ID: 28974138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, distribution, and risk factor correlates of high pericardial and intrathoracic fat depots in the Framingham heart study.
    Thanassoulis G; Massaro JM; Hoffmann U; Mahabadi AA; Vasan RS; O'Donnell CJ; Fox CS
    Circ Cardiovasc Imaging; 2010 Sep; 3(5):559-66. PubMed ID: 20525769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The obesity paradox].
    Du Pan RC; Golay A
    Rev Med Suisse; 2014 Jun; 10(436):1413-7. PubMed ID: 25055476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The link between abdominal obesity and the metabolic syndrome.
    Phillips LK; Prins JB
    Curr Hypertens Rep; 2008 Apr; 10(2):156-64. PubMed ID: 18474184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in circulating vitamin D levels with loss of adipose tissue.
    Gangloff A; Bergeron J; Lemieux I; Després JP
    Curr Opin Clin Nutr Metab Care; 2016 Nov; 19(6):464-470. PubMed ID: 27537278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of obesity indices, metabolic parameters and age on cardiac autonomic function in abdominally obese men.
    Poliakova N; Després JP; Bergeron J; Alméras N; Tremblay A; Poirier P
    Metabolism; 2012 Sep; 61(9):1270-9. PubMed ID: 22444779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From the BMI paradox to the obesity paradox: the obesity-mortality association in coronary heart disease.
    Antonopoulos AS; Oikonomou EK; Antoniades C; Tousoulis D
    Obes Rev; 2016 Oct; 17(10):989-1000. PubMed ID: 27405510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, Adipose Tissue and Vascular Dysfunction.
    Koenen M; Hill MA; Cohen P; Sowers JR
    Circ Res; 2021 Apr; 128(7):951-968. PubMed ID: 33793327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome.
    Pahwa R; Adams-Huet B; Jialal I
    J Diabetes Complications; 2017 May; 31(5):810-813. PubMed ID: 28285929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.